Globus Medical announced preliminary 4Q18 revenue of US $195.5MM, +11% vs. 4Q17, and full-year 2018 revenue of $712.5MM, +12% vs. 2017.
This marks the fifth consecutive quarter of double-digit organic growth for the company, driven in part by 35% year-over-year growth for the ExcelsiusGPS robotic platform. In the U.S., spinal implants grew 9%, which leadership attributed to robotic-system pull through and strong recruiting. Globus provided full-year 2019 guidance of $770MM.
Mike Evers is ORTHOWORLD’s Market Analyst. He can be reached by email.
Globus Medical announced preliminary 4Q18 revenue of US $195.5MM, +11% vs. 4Q17, and full-year 2018 revenue of $712.5MM, +12% vs. 2017.
This marks the fifth consecutive quarter of double-digit organic growth for the company, driven in part by 35% year-over-year growth for the ExcelsiusGPS robotic platform. In the U.S., spinal implants grew 9%,...
Globus Medical announced preliminary 4Q18 revenue of US $195.5MM, +11% vs. 4Q17, and full-year 2018 revenue of $712.5MM, +12% vs. 2017.
This marks the fifth consecutive quarter of double-digit organic growth for the company, driven in part by 35% year-over-year growth for the ExcelsiusGPS robotic platform. In the U.S., spinal implants grew 9%, which leadership attributed to robotic-system pull through and strong recruiting. Globus provided full-year 2019 guidance of $770MM.
Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.
Copy to clipboard 
